Journal article
Ramipril in the treatment of vascular diseases
Abstract
Ramipril is an angiotensin-converting enzyme inhibitor that has been extensively studied in randomised, controlled clinical trials in patients with cardiovascular diseases. Therapy with ramipril in patients with various cardiovascular disorders has demonstrated significant and clinically important reductions in cardiovascular death, myocardial infarction, stroke, congestive heart failure, progressive renal impairment and onset of diabetes. …
Authors
Rokoss MJ; Teo KK
Journal
Expert Opinion on Pharmacotherapy, Vol. 6, No. 11, pp. 1911–1919
Publisher
Taylor & Francis
Publication Date
September 2005
DOI
10.1517/14656566.6.11.1911
ISSN
1465-6566